Research Units | Job Offer | Job Search | Personnel support areas


 

PROBERT Lesley

Tel.: +30-1-6478866, 6478863

Fax: +30-1-6456547

e-mail: lesley_probert@hol.gr

 

Address

Laboratory of Molecular Genetics

Hellenic Pasteur Institute

127 Vassilissis Sophias Avenue

115 21 Athens - HELLAS

Research themes

TNF family signaling pathways in immune function and neuro-immune interactions. Neuroprotection and brain repair mechanisms. T cell differentiation and function. Gene expression profiling of CNS diseases.

Key words

TNF, TNF receptors, NF-kappaB, apoptosis, autoimmunity, multiple sclerosis, EAE, stroke, neuroprotection, transgenic, knockout, conditional gene targeting, CNS, T cells, neurons

Methods

Most methodologies in molecular and cellular biology (DNA analysis and manipulation, RNA and protein expression analysis, cellular immunology, immunocytochemistry, cell culture), expression of transgenes in cell lines and in mice, deletion or mutation of genes in mice, conditional gene targeting technology in vivo, microarrays, mouse models of autoimmunity, inflammation and neurodegeneration.

Composition of the research group

Sylva Haralambous

B.Sc, Ph.D, Biologist

Era Taoufik

B.Sc, M.Sc, Biologist

Vivi Tseveleki

B.Sc, M.Sc, Biochemist

Voula Lambropoulou

B.Sc, Medical Technologist

Maria Eugenidou

B.Sc, Biologist

Angelos Vagionas

M.Vet.Sci., Animal Technician

Recent publications

  1. TSEVELEKI V, BAUER J, TAOUFIK E, RUAN C, HARALAMBOUS S, LASSMANN H & PROBERT L. c-FLIPL overexpression in T cells is sufficient to drive Th2 effector responses and immunoregulation of experimental autoimmune encephalomyelitis. Submitted for publication January 2004.
  2. AKASSOGLOU K, BAUER J, TSEVELEKI V, LASSMANN H, PROBERT L & STRICKLAND S. Fibrin depletion decreases inflammation and delays the onset of demyelination in a in a tumor necrosis factor transgenic model offor multiple sclerosis. Proc. Natl. Acad. Sci. USA, in press February 2004.
  3. AKASSOGLOU K, DOUNI E, BAUER J, LASSMANN H, KOLLIAS G & PROBERT L (2003).Exclusive tumor necrosis factor signaling through the p75TNF receptor triggers inflammatory ischaemia in the central nervous system of transgenic mice. Proc. Natl. Acad. Sci. USA, 100, 709-714.
  4. PROBERT L, AKASSOGLOU K (2001). Glial expression of cytokines in transgenic animals - how do these models reflect the "normal situation". Invited Review. Glia, 36, 212-219.
  5. PROBERT L, EUGSTER H-P, AKASSOGLOU K, BAUER J, FREI K, LASSMANN H & FONTANA A (2000). TNFR1 signalling is critical for demyelination and the limitation of T-cell responses during immune-mediated CNS disease. Review, Brain, 123, 2005-2019.
  6. KASSIOTIS G, BAUER J, AKASSOGLOU K, LASSMANN H, KOLLIAS G & PROBERT L (1999). A tumor necrosis factor-induced model of human primary demyelinating diseases develops in immunodeficient mice. Eur. J. Immunology 29: 912-917.
  7. KASSIOTIS G, PASPARAKIS M, KOLLIAS G & PROBERT L (1999).TNF accelerates the onset but does not alter the incidence and severity of myelin basic protein-induced experimental autoimmune encephalomyelitis. Eur. J. Immunology 29: 774-780.
  8. AKASSOGLOU K, BAUER J, KASSIOTIS G, PASPARAKIS M, LASSMANN H, KOLLIAS G & PROBERT L (1998). Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the CNS of transgenic mice: Models for Multiple Sclerosis with primary oligodendropathy. Am. J. Pathol. 153: 801-813.
  9. AKASSOGLOU K, PROBERT L, KONTOGEORGOS G & KOLLIAS G (1997) Astrocyte- but not Neuron-Specific Transmembrane TNF Triggers Inflammation, Demyelination and Neuronal Degeneration in the CNS of Transgenic Mice. J. Immunol. 158: 438-445.
  10. PROBERT L, AKASSOGLOU K, PASPARAKIS M, KONTOGIORGOS G & KOLLIAS G (1995). Spontaneous inflammatory demyelinating disease in transgenic mice showing CNS-specific expression of tumor necrosis factor. Proc. Natl. Acad. Sci. USA 92: 11294-11298.
  11. PROBERT L, PLOWS D, KONTOGEORGOS G & KOLLIAS G. (1995) The type I IL-1 receptor acts in series with TNF to induce arthritis in TNF transgenic mice. Eur. J. Immunol. 25: 1794-1797.